Prima to Present at 2016 Society for Immunotherapy of Cancer Conference – Yahoo Finance
|
Prima to Present at 2016 Society for Immunotherapy of Cancer Conference
Yahoo Finance SYDNEY, AUSTRALIA–(Marketwired – Oct 12, 2016) – Prima BioMed Ltd ( ASX : PRR ) ( NASDAQ : PBMD ) ("Prima") announces that the submission titled "LAG-3Ig (IMP321) in combination with anti-PD-1 therapy" has been accepted for a presentation at the … |
